"Associates in Gastroenterology has proven time again the services they provide are among the best. We are one of the most trusted names in digestive health care. For over 20 years, we have served as the premier gastroenterologists through all our locations. Providing unparalleled services and having an excellent track record are what we take pride in. If you need a gastroenterologist that will treat you like family and provide you the care you need by utilizing the latest technologies, take the time out of your day and call us! We offer gastroenterology care with multiple services, including, colonoscopy, color cancer screening, liver health screenings, and many more."

During the past decade, Digestive Health Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Digestive Health Research" #1 sponsor was "Tobira Therapeutics, Inc." with 2 trials, followed by "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "HighTide Biopharma Pty Ltd" with 1 trials sponsored, "ImmusanT, Inc." with 1 trials sponsored and "Inventiva Pharma" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Digestive Health Research" are "Nonalcoholic Steatohepatitis" (3 trials), "Nonalcoholic Fatty Liver Disease" (2 trials), "Autoimmune Diseases" (1 trials), "Celiac" (1 trials) and "Celiac Disease" (1 trials). Many other conditions were trialed in "Digestive Health Research" in a lesser frequency.

Most popular intervention types in "Digestive Health Research" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cenicriviroc" (2 trials), "EDP-305 1.5 mg" (1 trials), "EDP-305 2 mg" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Health Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Health Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Digestive Health Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Health Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".